Why PMCF Plans Fail at Technical Documentation Review
The MDR Annex XIV requirement is explicit: the PMCF plan must address the residual clinical risks and performance gaps identified in the Clinical Evaluation Report. Notified Bodies reject plans that treat PMCF as a generic follow-up study rather than a targeted response to CER-identified gaps. The clinical affairs team's challenge is that CER gap analysis and PMCF study design are typically handled sequentially by different team members, with no structured handoff between gap identification and study objective formulation — leaving the traceability between them implicit rather than documented.
Traceability-First PMCF Design With an AI Agent
An AI Labor Company agent extracts PMCF study design alignment logic from your historical CER gap analyses and patterns from prior Notified Body feedback, working across Veeva Vault QualityDocs and Vault CTMS. The agent maps each CER clinical performance gap to specific PMCF study objectives, generates a gap-to-study-design traceability matrix in the format Notified Bodies expect under MDR 2017/745 Annex XIV, and queues it — with Medidata Rave and REDCap data collection plan elements attached — for the clinical affairs director's review before NB submission. The traceability gap that caused the first rejection becomes the starting artifact, not an afterthought.
The Business Case: Avoiding a Second Rejection Cycle
The direct cost avoided here is a second Notified Body rejection cycle — another six to twelve months and another round of study redesign spend on top of the $1.5M–$6M program already committed. Beyond the immediate risk, getting PMCF right the first time preserves your MDR technical documentation status and keeps the device's EU market access intact. Teams in this position typically see the gap analysis and traceability matrix phase compressed by 45–65%, with a structured, defensible PMCF design ready for NB submission in roughly ten weeks from agent deployment.
Can the agent work from our existing CER or does it require a specific format?
The agent processes CER documents as they exist in Vault QualityDocs, extracting clinical performance gaps from the structure and language your team used. It doesn't require a reformatted CER — that would defeat the purpose.
Does the traceability matrix format align with what our Notified Body specifically expects?
The agent is configured against MDR 2017/745 Annex XIV requirements, and the traceability matrix format is adjusted based on feedback patterns from prior NB reviews in your document history. If your NB has expressed specific format preferences in past correspondence, those are incorporated.
How does this integrate with the Medidata Rave study we're planning?
The agent maps the PMCF study objectives to data collection requirements and flags the relevant eCRF fields in Medidata Rave and REDCap that correspond to each gap-driven endpoint. The data collection plan is generated alongside the traceability matrix.